Related Experiment Video
Updated: Jun 1, 2026
05:12
Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
Profile of liver dysfunction in alchohol dependence
N G Desai1, M Vaswani, B S Chavan
1Dr. Nimesh G. Desai, M.D., Additional Professor in Psychiatry, The Drug Dependence Treatment Centre & Department of Psychiatry, AIIMS, New Delhi-110 029.
Indian Journal of Psychiatry
|May 18, 2011
Summary
Alcohol dependence frequently causes liver dysfunction, even in patients without symptoms. This study highlights the high prevalence of biochemical liver abnormalities in individuals seeking treatment for alcohol use disorder.
Area of Science:
- Hepatology
- Addiction Medicine
- Clinical Biochemistry
Background:
- Alcohol dependence is a significant global health issue.
- Liver disease is a common complication of chronic alcohol abuse.
- Early detection of liver dysfunction is crucial for patient outcomes.
Purpose of the Study:
- To assess the prevalence of liver dysfunction in patients with alcohol dependence.
- To identify biochemical evidence of liver damage in asymptomatic individuals.
- To contextualize findings within existing Indian research on alcohol-related liver disease.
Main Methods:
- Retrospective analysis of biochemical liver function tests.
- Study conducted at a specialized drug dependence treatment center.
- Inclusion of 92 patients diagnosed with alcohol dependence.
Main Results:
- A high proportion of patients exhibited biochemical evidence of liver dysfunction.
- Liver abnormalities were detected even in patients presenting without clinical signs or symptoms.
- Findings indicate subclinical liver damage is prevalent in this cohort.
Conclusions:
- Alcohol dependence is strongly associated with significant liver dysfunction.
- Routine liver function monitoring is essential for all patients with alcohol dependence, regardless of clinical presentation.
- Further research is warranted to understand the long-term implications and management strategies for subclinical liver damage in this population.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...